The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the ETP Ventures, startups are often financed by GoBeyond, PPF Group. The meaningful sponsors for the fund in investment in the same round are PPF Group, Huatai Zijin Investment, FC Capital. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.
Among the most popular portfolio startups of the fund, we may highlight Cellestia Biotech. Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| 1UP | - |
| Ambrosia Investments | Luxembourg, Luxembourg |
| Bengo 4.com | Chiba Prefecture, Japan, Tateyama |
| Brohuvudet | - |
| GoPhillyFund | - |
| Groupe Revue Fiduciaire | - |
| Hakuhodo | Chiba, Japan, Minato |
| Istithmar | Dubai, United Arab Emirates |
| Jade Capital | Beijing, Beijing, China |
| Jindagi Live Angels | - |
| Legendary Ventures | New York, New York, United States |
| Liveris Family Office | - |
| MedStar Health | Columbia, Maryland, United States |
| Minamidsuka Industry | - |
| Port of Seattle | Seattle, United States, Washington |
| Residence Ventures | New York, New York, United States |
| The Grover Trust | - |
| Vista Credit Partners | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SEIMEI | $4M | 18 Nov 2022 | Changyang, Beijing, China | ||
Deep Longevity | 14 Jul 2020 | Hong Kong Island, Hong Kong | |||
Dima Biotech | 11 Sep 2019 | Suzhou, Jiangsu, China | |||
Cellestia Biotech | $21M | 19 Dec 2018 | Lausanne, Vaud, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SEIMEI | $4M | 18 Nov 2022 | Changyang, Beijing, China | ||
Deep Longevity | 14 Jul 2020 | Hong Kong Island, Hong Kong | |||
Dima Biotech | 11 Sep 2019 | Suzhou, Jiangsu, China | |||
Cellestia Biotech | $21M | 19 Dec 2018 | Lausanne, Vaud, Switzerland |
